Marshall Financial Group (Maryland)’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,249
| Closed | -$792K | – | 268 |
|
|
2025
Q1 | $792K | Buy |
1,249
+279
| +29% | +$177K | 0.17% | 141 |
|
|
2024
Q4 | $691K | Buy |
+970
| New | +$691K | 0.17% | 139 |
|
|
2024
Q2 | – | Sell |
-1,022
| Closed | -$984K | – | 190 |
|
|
2024
Q1 | $984K | Buy |
1,022
+90
| +10% | +$86.6K | 0.28% | 97 |
|
|
2023
Q4 | $819K | Buy |
932
+71
| +8% | +$62.4K | 0.26% | 107 |
|
|
2023
Q3 | $709K | Buy |
861
+11
| +1% | +$9.05K | 0.26% | 102 |
|
|
2023
Q2 | $611K | Buy |
850
+46
| +6% | +$33.1K | 0.21% | 116 |
|
|
2023
Q1 | $661K | Buy |
+804
| New | +$661K | 0.24% | 114 |
|
|
2022
Q2 | – | Sell |
-1,764
| Closed | -$1.23M | – | 208 |
|
|
2022
Q1 | $1.23M | Buy |
1,764
+71
| +4% | +$49.6K | 0.5% | 67 |
|
|
2021
Q4 | $1.07M | Buy |
1,693
+239
| +16% | +$151K | 0.39% | 88 |
|
|
2021
Q3 | $880K | Buy |
1,454
+114
| +9% | +$69K | 0.46% | 70 |
|
|
2021
Q2 | $748K | Buy |
+1,340
| New | +$748K | 0.4% | 79 |
|